Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypercholesterolemia or Combined Dyslipidemia”

Showing 15 of 0 results

Large-scale testing (Phase 3)Study completedNCT00286481
What this trial is testing

Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Takeda 1,362
Large-scale testing (Phase 3)Ended earlyNCT01294683
What this trial is testing

Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)

Who this might be right for
Primary HypercholesterolemiaDyslipidemia
Merck Sharp & Dohme LLC 977
Early research (Phase 1)Study completedNCT06742853
What this trial is testing

Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

Who this might be right for
Dyslipidemia
AstraZeneca 81
Testing effectiveness (Phase 2)Study completedNCT02591836
What this trial is testing

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin

Who this might be right for
Hypercholesterolemia
NeuroBo Pharmaceuticals Inc. 277
Large-scale testing (Phase 3)Study completedNCT00249912
What this trial is testing

Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Takeda 415
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Large-scale testing (Phase 3)Study completedNCT00653445
What this trial is testing

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg

Who this might be right for
HypercholesterolemiaCoronary Heart DiseaseAtherosclerosis
AstraZeneca
Not applicableLooking for participantsNCT06686615
What this trial is testing

Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2,000
Large-scale testing (Phase 3)Study completedNCT00535405
What this trial is testing

Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

Who this might be right for
Hypercholesterolemia
Organon and Co 1,289
Not applicableLooking for participantsNCT07083206
What this trial is testing

Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

Who this might be right for
HypercholesterolemiaDyslipidemias
Ahn-Gook Pharmaceuticals Co.,Ltd 4,500
Large-scale testing (Phase 3)Study completedNCT00309738
What this trial is testing

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Who this might be right for
HypercholesterolemiaDyslipidemia
Kowa Research Europe 355
Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409
Large-scale testing (Phase 3)Ended earlyNCT00249899
What this trial is testing

Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Takeda 649
Large-scale testing (Phase 3)Study completedNCT07444762
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Daewon Pharmaceutical Co., Ltd. 184
Testing effectiveness (Phase 2)Study completedNCT01105975
What this trial is testing

LY2484595 in Patients With High LDL-C or Low HDL-C

Who this might be right for
Dyslipidemia
Eli Lilly and Company 398

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation